Connect with us

Hi, what are you looking for?

Tuesday, Jan 25, 2022
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

Business

Curaleaf to raise US$425M from private placement

The firm says the low interest rate will allow it to refinance its debt

Curaleaf to raise US$425M from private placement
Photo via Curaleaf

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) says it’s going to receive the largest debt financing of any publicly traded multi-state cannabis operator to date.

On Monday the U.S.-based company said it’s received commitments for a private placement of 8-per-cent senior secured notes due in 2026, for gross proceeds of US$425 million.

The offering will allow Curaleaf to refinance its existing debt at a lower interest rate, and provide it more financial flexibility to execute growth initiatives, CEO Joseph Bayern says in a statement.

At the end of its third fiscal quarter, the firm reported having US$342 million in outstanding debt net of unamortized discounts.

Read more: Curaleaf ‘on track’ to hit US$1.2B sales target despite flat growth in Q3

According to a statement, the notes will be issued at 100 per cent of face value and bear interest at 8 per cent a year, payable semi-annually in equal installments until the maturity date of Dec. 15, 2026, unless redeemed or rebought earlier.

The notes will be governed by a trust indenture, which Curaleaf says allows it to issue additional notes as needed, and up to another US$200 million in senior bank financing.

“While this initial offering provides more than enough liquidity to refinance our existing debt and meet current needs, the new indenture provides us a new degree of flexibility to raise debt financing to ensure we have ample liquidity to meet our needs now and into the future,” Bayern says.

The offering is expected to close on Wednesday.

Seaport Global Securities LLC and Canaccord Genuity Corp. acted as placement agents for the notes in the U.S. and Canada, respectively.

The notes will be subject to a customary four-month hold period under Canadian securities laws.

As it posted its third-quarter results in November, Curaleaf said it was on track to hit a US$1.2-billion sales target despite flat growth. During the three-month period, the company reported a US$59-million loss.

Company stock fell around 3 per cent Monday to $11.71 on the Canadian Securities Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe